Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry

NCT02429505 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped This study was COMPLETED, but no patients were enrolled.

Conditions

Leishmaniasis

Interventions

DRUG: Miltefosine

Sponsor

Knight Therapeutics (USA) Inc